Cameron Santoro is an associate editor for The American Journal of Managed Care® (AJMC®), AJMC.com, and The Center for Biosimilars®.
Breast Cancer Risk Not Linked to SSRIs; Prolactin Levels Warrant Careful Prescribing
A recent study found a minor link between prolactin levels and the risk of developing estrogen receptor (ER)-positive or ER-negative breast cancers. However, there was no association found between the use of selective serotonin reuptake inhibitors (SSRIs) and breast cancer risk.
Combination Therapies Optimize Hair Regrowth in Pediatric Patients With AA
Corticosteroids are the most common treatment for pediatric patients with alopecia areata (AA), but promising newer options like JAK inhibitors are emerging. This review highlights the importance of personalized treatment plans and maximizing response through combination therapies.
Supporting Breast Cancer Survivors Through Psychosocial Challenges
Breast cancer survivors face a complex landscape of challenges including lingering symptoms, anxieties about the future, identity shifts, and potential social isolation. However, the study identifies personal growth fostered by the experience, further underscoring the critical role of social support and open communication with health care providers in navigating this journey.
Cryoablation Exhibits Advantages as Minimally Invasive Option for Early Breast Cancer
While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires further research for wider adoption.
Light Therapy Clothing Shows Potential for Mild Psoriasis, PMLE, AA Treatment
Red and near-infrared–emitting fabric clothing may improve symptoms of mild psoriasis, polymorphous light eruption (PMLE), and alopecia areata (AA), but further research with larger groups is needed due to limitations in the pilot study design.
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Alopecia Areata Impacts Patient Perception, Quality of Life
Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Deuruxolitinib Demonstrates Efficacy, Tolerability in Patients With Moderate to Severe AA
Posters suggest deuruxolitinib, a medication targeting specific cellular pathways, effectively promotes hair regrowth in patients with moderate to severe alopecia areata (AA) and results in minimal adverse events.
Night Light Pollution Linked to Breast Cancer, Particularly for Asian Populations, ER+ Cases
A large-scale study suggests increased light at night exposure is linked to a higher risk of breast cancer, particularly in Asian populations and women with estrogen receptor-positive tumors (ER+).
Stable Treatment Remained in Early Breast Cancer Diagnosis During Pandemic
A study of patients diagnosed with early breast cancer during the COVID-19 pandemic found that the public health crisis did not produce significant changes in or delays treatment, despite many women presenting with palpable tumors.
Experts Measure AA Severity With Key Factors, Reach Consensus on Treatment Decisions
An expert survey using the eDelphi method pinpointed disease duration, treatment response, and mental health as crucial factors in a new multidimensional tool known as Alopecia Areata Severity and Morbidity Index (ASAMI), underlining the importance of personalized treatments for future research incorporating patient perspectives.
Multigene Assays Advance Genetic Testing in Breast Cancer, Drive Personalized Medicine
Multigene assays allow for patients to receive personalized breast cancer treatment by identifying promising therapeutic targets, which could improve patient clinical outcomes in the long term and help providers better understand tumor biology.
Biosimilar HLX01 Demonstrates Bioequivalence With Rituxan in DLBCL
A new study has found that HLX01 (HanliKang), a rituximab biosimilar, had comparable overall survival and progression-free survival rates to the reference product (Rituxan) in patients with diffuse large B-cell lymphoma (DLBCL).
Swedish Study Links False-Positive Mammograms to Elevated Breast Cancer Risk
Swedish women with prior false-positive mammograms, particularly those aged 60 to 75 with prior biopsies and low density, show elevated breast cancer risk, necessitating closer monitoring and better screening.
Cultural Influences, Surgical Decision-Making Approaches for Non-Caucasian Women With Breast Cancer
Non-Caucasian patients with breast cancer face common influences in surgical decision-making due to fear, misinformation, cultural factors, and power dynamics, highlighting the need for patient-centered surgical decision-making.
Study Finds AA Associated With Connective Tissue, Ocular Diseases and Vitamin D Deficiency
Meta-analysis results identify high and low associations of various comorbidities like vitamin D deficiencies, ocular diseases, among others in patients with alopecia areata (AA), to promptly manage and improve treatment outcomes.
Study Finds Significant Hair Regrowth in Patients With Patchy AA Following Baricitinib Treatment
Baricitinib was found to be an effective treatment for patchy alopecia areata (AA), in a retrospective study, with most patients experiencing hair regrowth after 4 to 16 weeks of treatment.